Larvol Delta - Positive-guidance-from-the-US-FDA-on-64CuSARbisPSMA-Phase-III-trial-in-patients-with-recurrence-of-prostate-cancer

67Cu-SAR-bisPSMA - Clarity Pharma

https://www.prnewswire.com/news-releases/positive-guidance-from-the-us-fda-on-64cu-sar-bispsma-phase-iii-trial-in-patients-with-recurrence-of-prostate-cancer-302274687.html

Oct 14, 2024

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next